Key result
Review-workflow text provides no clinical data on inflammation in acute coronary syndromes.
Why the study?
Evolving reperfusion methodologies and understanding of ACS management invite integration of recent findings on inflammation and circulating biomarkers into contemporary clinical practice.
Answers are grounded in this paper and cite their sources.
Reviews inflammatory pathways and evolving reperfusion strategies in acute coronary syndromes, highlighting the need to integrate modern biomarker insights into contemporary clinical practice.
Atherosclerosis is the focal expression within the artery of a systemic disease, in which traditional cardiovascular risk factors and immune factors play a key role. It is well accepted that circulating biomarkers, reliably predict major cardiovascular events, including acute coronary syndromes (ACS) or death. The therapeutic management of patients with ACS in the last decade has shown a dramatic evolution in the understanding of reperfusion. The constant changes in the methodology of reperfusion invite to integrate the recent findings for a better management in the contemporary clinical practice [1-5].
No takes yet. Share an insight, caveat, or question.
Osmar Antonio Centurión (2015) studied Acute Coronary Syndromes. Inflammation in acute coronary syndromes was referenced in the title, but the provided text contained only journal peer-review workflow boilerplate without clinical data.
Synapse has enriched 10 related papers. Consider them for comparative context: